Clinical judgment and treatment




Alzheimer, diagnósticos, demência, cognição


Patients from various backgrounds come to the Psychosocial Care Centres in their respective regions in Brazil, where care is provided on spontaneous demand from patients or through referral from a specialized primary medical unit, be it an emergency or clinical/psychiatric hospitalization, and inevitably the professional who sees this patient needs to lead to a diagnosis or initially base it on a clinical judgment, as part of the first assessment of the condition. When the demand is for a judgment of dementia, which is based on the assumption of chronic, global and generally irreversible degeneration of cognition, although based on the clinical diagnosis, it is important to proceed to confirmation through laboratory and imaging tests, which will serve to identify the treatable causes. However, clinical decision-making about what to do next with a patient depends much more on clinical judgment, to establish the severity of the symptoms and the factors affecting the patient's life, as well as their real hopes for treatment with the available and approved drug therapies and the outcome they expect.


Dou, KX., Tan, MS., Tan, CC. e outros Segurança comparativa e eficácia dos inibidores da colinesterase e memantina para a doença de Alzheimer: uma meta-análise de rede de 41 ensaios clínicos randomizados. Alz Res Therapy 10 , 126 (2018).

ENGELHARDT, E. et al. Tratamento da Doença de Alzheimer. Arq Neuropsiquiatr, v. 63, n. 4, p.1104-1112, 2005.

FERREIRA, S; MASSANO, J. Terapêutica Farmacológica na Doença de Alzheimer: Progressos e Esperanças Futuras. Arquivos de Medicina, v. 27, n. 2, p. 65-86, 2013.

Ferreira-Vieira, T. H., Guimaraes, I. M., Silva, F. R., & Ribeiro, F. M. (2016). Alzheimer's disease: Targeting the Cholinergic System. Current neuropharmacology, 14(1), 101–115.

FORLENZA, O. V. Tratamento Farmacológico da Doença de Alzheimer. Rev. Psiq. Clín. v. 32, n. 3, p. 137-148, 2005.

Gong, C. X., & Iqbal, K. (2008). Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease. Current medicinal chemistry, 15(23), 2321–2328.

Grossberg G. T. (2003). Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on. Current therapeutic research, clinical and experimental, 64(4), 216–235.

INOUYE, K; OLIVEIRA, G. H. Avaliação Crítica do Tratamento Farmacológico Atual Para a Doença de Alzheimer. Infarma, v. 15, n. 12, jan., 2004

JARVIS, B.; FIGGITT, D. P. Memantine. Drugs Aging, v. 20, n. 6, p. 465-476, 2003.

LIMA, d. a. Tratamento Farmacológico da Doença de Alzheimer. Revista do Hospital Universitário Pedro Ernesto, n. 7, jan./jun., Rio de Janeiro, 2008.

Li, Y., Schindler, S. E., Bollinger, J. G., Ovod, V., Mawuenyega, K. G., Weiner, M. W., Shaw, L. M., Masters, C. L., Fowler, C. J., Trojanowski, J. Q., Korecka, M., Martins, R. N., Janelidze, S., Hansson, O., & Bateman, R. J. (2022). Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques. Neurology, 98(7), e688–e699.

Hill, E., Clifton, P., Goodwill, A. M., Dennerstein, L., Campbell, S., & Szoeke, C. (2018). Dietary patterns and β-amyloid deposition in aging Australian women. Alzheimer's & dementia (New York, N. Y.), 4, 535–541.

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet. 2020;396:413–46. doi:10.1016/S0140-6736(20)30367-6. - DOI - PMC - PubMed

Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol. 2009;44:136–40. doi:10.1093/alcalc/agn102. - DOI - PubMed

Matéria de site:

World Health Organization. Global action plan on the public health response to dementia 2017–2025. Geneva: World Health Organization; 2017, p. 27.

Matéria de site: Acesso em: 10 de janeiro de 2023.

SILVA, P. Farmacologia. 8. ed., Rio de Janeiro: Guanabara Koogan, 2010.

Whalen, K.; Finkel, R.; Panavelil, T. A. Farmacologia ilustrada. 6. ed. Porto Alegre: Artmed, 2016.

Wilson, R. S., Segawa, E., Boyle, P. A., Anagnos, S. E., Hizel, L. P., & Bennett, D. A. (2012). The natural history of cognitive decline in Alzheimer's disease. Psychology and aging, 27(4), 1008–1017.



How to Cite

Souza, R. S., & Menegucci, D. R. (2023). THE DIAGNOSIS OF ALZHEIMER’S AND COGNITIVE DISORDER: Clinical judgment and treatment. Biofarma - Multidisciplinary Scientific Journal of Biology, Pharmacy and Health, 3(3).